AstraZeneca Group (AZN)
AstraZeneca Group Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 41.02 | 41.36 | 41.02 | 41.23 | 770432 |
| May 24, 2012 | 41.18 | 41.43 | 40.97 | 41.18 | 982432 |
| May 23, 2012 | 41.33 | 41.34 | 40.76 | 41.06 | 1306026 |
| May 22, 2012 | 41.68 | 41.97 | 41.49 | 41.62 | 1398365 |
| May 21, 2012 | 41.75 | 42.24 | 41.72 | 42.21 | 1401885 |
| May 18, 2012 | 41.63 | 41.69 | 41.26 | 41.46 | 1305029 |
| May 17, 2012 | 41.87 | 42.06 | 41.65 | 41.65 | 2948543 |
| May 16, 2012 | 42.17 | 42.38 | 42.04 | 42.25 | 2412473 |
| May 15, 2012 | 42.48 | 42.71 | 42.31 | 42.39 | 1057602 |
| May 14, 2012 | 42.82 | 43.12 | 42.70 | 42.86 | 950114 |
| May 11, 2012 | 43.16 | 43.65 | 43.15 | 43.45 | 912190 |
| May 10, 2012 | 43.58 | 43.63 | 43.27 | 43.34 | 1078321 |
| May 9, 2012 | 43.15 | 43.68 | 42.96 | 43.44 | 1490533 |
| May 8, 2012 | 44.12 | 44.15 | 43.58 | 43.99 | 1250859 |
| May 7, 2012 | 43.74 | 44.03 | 43.66 | 43.96 | 1408427 |
| May 4, 2012 | 44.40 | 44.53 | 43.84 | 43.90 | 1116012 |
| May 3, 2012 | 44.19 | 44.48 | 44.01 | 44.40 | 1615963 |
| May 2, 2012 | 43.83 | 44.12 | 43.72 | 44.09 | 1587184 |
| May 1, 2012 | 44.11 | 44.43 | 44.04 | 44.29 | 1725521 |
| April 30, 2012 | 43.73 | 44.03 | 43.69 | 43.90 | 1810784 |
| April 27, 2012 | 43.42 | 43.69 | 43.21 | 43.55 | 2092056 |
| April 26, 2012 | 43.30 | 43.57 | 43.00 | 43.36 | 8291107 |
| April 25, 2012 | 45.46 | 45.95 | 45.41 | 45.91 | 1612316 |
| April 24, 2012 | 45.63 | 45.98 | 45.56 | 45.82 | 1063209 |
| April 23, 2012 | 45.64 | 45.65 | 45.15 | 45.54 | 1528249 |
| April 20, 2012 | 45.97 | 46.35 | 45.93 | 46.22 | 2440317 |
| April 19, 2012 | 45.37 | 45.52 | 45.13 | 45.39 | 1103572 |
| April 18, 2012 | 45.41 | 45.50 | 45.27 | 45.38 | 971497 |
| April 17, 2012 | 44.96 | 45.40 | 44.89 | 45.27 | 1104432 |
| April 16, 2012 | 44.48 | 44.72 | 44.30 | 44.72 | 1052016 |
| April 13, 2012 | 44.55 | 44.63 | 44.15 | 44.22 | 1108693 |
| April 12, 2012 | 44.48 | 45.09 | 44.44 | 45.03 | 2097027 |
| April 11, 2012 | 43.95 | 44.70 | 44.36 | 44.42 | 3511233 |
| April 10, 2012 | 44.50 | 44.69 | 43.81 | 43.95 | 2104003 |
| April 9, 2012 | 44.13 | 44.27 | 43.95 | 44.05 | 1122087 |
| April 5, 2012 | 44.01 | 44.28 | 44.01 | 44.20 | 1065220 |
| April 4, 2012 | 44.77 | 44.78 | 44.13 | 44.37 | 1420118 |
| April 3, 2012 | 45.49 | 45.51 | 44.86 | 45.07 | 1335671 |
| April 2, 2012 | 44.65 | 45.48 | 44.62 | 45.28 | 1527772 |
| March 30, 2012 | 44.64 | 44.74 | 44.45 | 44.49 | 1856652 |
| March 29, 2012 | 44.32 | 44.64 | 44.13 | 44.50 | 3413427 |
| March 28, 2012 | 45.03 | 45.17 | 44.41 | 44.67 | 3269014 |
| March 27, 2012 | 45.24 | 45.34 | 45.11 | 45.27 | 2737792 |
| March 26, 2012 | 45.28 | 45.69 | 45.25 | 45.65 | 371328 |
| March 23, 2012 | 45.14 | 45.27 | 43.15 | 45.18 | 1579612 |
| March 22, 2012 | 45.06 | 45.36 | 45.04 | 45.30 | 2383687 |
| March 21, 2012 | 45.53 | 45.73 | 45.28 | 45.42 | 540965 |
| March 20, 2012 | 45.15 | 45.72 | 45.10 | 45.68 | 1788226 |
| March 19, 2012 | 45.08 | 45.55 | 45.06 | 45.38 | 871809 |
| March 16, 2012 | 44.89 | 45.14 | 44.84 | 45.11 | 1090755 |
AZN News
$AZN stop at 40 on 1/3. Have owned a ton of it since early '10. Cost basis ~46 (not inc. divies)
about 4 days ago by WallStreetBean
about 4 days ago by WallStreetBean
RT @SeemaCnbc Cancer data expected to move big pharma $JNJ $PFE $AZN
about 10 days ago by StockTwits
about 10 days ago by StockTwits
$AZN “no longer operating in isolation as a pharmaceutical organization.” http://stks.co/3nwQ
about 14 days ago by WallStreetBean
about 14 days ago by WallStreetBean
AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in Certain Asthma Patient Groups
May 10, 9:02AM Street Insider
May 10, 9:02AM Street Insider
UPDATE - Canaccord Genuity Downgraded Ardea Biosciences (RDEA) To 'Hold'; Q1 Is Non-Event In Light Of Acquisition By AZN
May 08, 9:14AM Street Insider
May 08, 9:14AM Street Insider
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 20 days ago by abubnic
about 20 days ago by abubnic
$AMRN U.K.'s second-biggest drugmaker, pharmaceutical giant $AZN, based in London is sniffing around Ireland's small biotech $AMRN
about 23 days ago by JasonMilano8
about 23 days ago by JasonMilano8
News related to $AZN, currently +0.3% since open: 'Impax Labs falls on weak sales, new FDA warning' http://stks.co/3bhx
about 26 days ago by TradeBot
about 26 days ago by TradeBot
what kinda drug is that? RT @JNapodano $AZN reported $16M in sales of Vimovo - not great, but still higher than consensus. $POZN.
about 27 days ago by WallStreetBean
about 27 days ago by WallStreetBean
Morning News: April 26, 2012 | via @EddyElfenbein http://stks.co/3Wht $FED $DB $NDX $AAPL $CAT $AZN
about 31 days ago by STNet
about 31 days ago by STNet
$AZN trouble in paradise: AstraZeneca CEO to step down as Q1 profit plunges http://stks.co/3WZ3 (holding)
about 31 days ago by WallStreetBean
about 31 days ago by WallStreetBean
News related to $AZN: 'AstraZeneca CEO to step down as Q1 profit plunges' http://stks.co/3WIC
about 32 days ago by TradeBot
about 32 days ago by TradeBot
@taketheplunge $AMRN $AZN has been linked to every biotech on the market in the last 3 months. $AZN could buy...
about 32 days ago by jackofalltrade
about 32 days ago by jackofalltrade
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AZN | 41.23 | +0.05 | +0.12% | 53.28B |
| AZK | 4.72 | +0.11 | +2.39% | 769.97M |
| AZC | 1.63 | +0.13 | +8.67% | 235.05M |
| AYR | 11.60 | +0.37 | +3.29% | 839.61M |
| BCRX | 3.26 | +0.00 | +0.00% | 150.09M |
| BCR | 99.90 | -0.09 | -0.09% | 8.473B |
| BCPC | 30.31 | -0.25 | -0.82% | 885.36M |
| BCOM | 4.20 | +0.01 | +0.24% | 125.54M |
| BCO | 23.23 | -0.32 | -1.36% | 1.089B |
| BCH | 84.05 | +0.83 | +1.00% | 12.18B |